Science

Apr 24, 2025, 10:12

Myeloma Paper of the Day, April 24th, suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: IVIg supplementation in recipients of BCMA-directed TCEs for myeloma may be associated with improved outcomes, including favorable infection-free and overall survival; extramedullary and high-risk disease confer poor outcomes.”

“Effect of Intravenous Immunoglobulin (IVIG) Supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma”

Authors: Meera Mohan, Aniko Szabo, Heloise Cheruvalath, Anna Clennon, Vineel Bhatlapenumarthi, Anita D’Souza, Nishi Shah, Rajshekhar Chakraborty, Mansi Shah, Carolina Schinke et al.

More posts featuring Robert Orlowski.

Aniko Szabo Anita D'Souza Anna Clennon cancer Carolina Schinke Heloise Cheruvalath Intravenous Immunoglobulin IVIG Mansi Shah Meera Mohan multiple myeloma Myeloma Paper of the Day Nishi Shah OncoDaily Oncology Rajshekhar Chakraborty Robert Orlowski Vineel Bhatlapenumarthi

Marking One Year of Progress in IDH-Mutant Glioma Treatment - Servier Pharmaceuticals

James Whale Dies at 74: The Radio Icon’s Long Fight Against Kidney Cancer

A Pivotal Day for Geron

Top GU Immunotherapy Trials to Watch at ESMO 2025

Julie Gralow Received the 2025 NCG Lifetime Achievement Award in Oncology